Turning Point Therapeutics Inc.

10/23/2021 | Press release | Distributed by Public on 10/23/2021 07:28

Turning Point Therapeutics Presents Early Clinical Data for Repotrectinib From Care Study in Pediatric and Young Adult Patients at SIOP 2021 Virtual Congress